HAEMATOLOGY

6 FEBRUARY 2018

Overview

There have been several new developments in the field of haematology and oncology. Focusing on the lab testing and interpretation of treatment of blood-related diseases, the CME- accredited Haematology conference provides an opportunity to the delegates to discuss the emerging therapeutic options and recognise the factors that affect the diagnosis, staging, and prognosis of patient’s treatments.

Key topics:

  • Quality assurance in haematology
  • Revised 2016 WHO classification of Lymphoid Neoplasms
  • Minimal Residual disease in Myeloma
  • Transfusion support for transplant patients
  • Future of transfusion medicine
     

Benefits of attending:

  • Evaluate quality improvement in haematology practices
  • Discuss updates on WHO classification
  • Identify pitfalls and their impact on laboratory results and interpretation
  • Determine challenges in quality assurance in haematology
  • Review approaches in screening results in the day to day clinical practice

Chair: Dr Rania Medhat Seliem, Consultant Hematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai, UAE     
Activity Director: Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA